col.name,col.class,uniqueness,requiredness,multiplevalues,description,allowedvalues,ontology
study_name,character,non-unique,optional,FALSE,Dataset name.,[a-zA-Z-]+_[0-9]{4}|[a-zA-Z-]+_[0-9]{4}[a-zA-Z-]+|[a-zA-Z-]+_[0-9]{4}_[a-zA-Z-]+|[a-zA-Z-]+_[0-9]{4}_[a-zA-Z0-9]+,NA
sample_id,character,unique,required,FALSE,Sample identifier.,[0-9a-zA-Z]\S+,NA
subject_id,character,non-unique,required,FALSE,Subject identifier.,[0-9a-zA-Z]\S+,NA
age,integer,non-unique,optional,FALSE,Age of the subject using the unit specified under 'age_unit' column,[0-9]+,NA
age_group,character,non-unique,optional,FALSE,11 <= Adolescent < 18|18 <= Adult < 65|2 <= Children 2-11 Years Old < 11|65 <= Elderly < 130|0 <= Infant < 2,Adolescent|Adult|Children 2-11 Years Old|Elderly|Infant,NCIT:C27954|NCIT:C49685|NCIT:C49683|NCIT:C16268|NCIT:C27956
age_unit,character,non-unique,optional,FALSE,Unit of the subject's age specified under 'age' column,Day|Week|Month|Year,NCIT:C25301|NCIT:C29844|NCIT:C29846|NCIT:C29848
antibiotics_current_use,character,non-unique,optional,FALSE,Antibiotics current usage. `Yes` for currently using and `No` for not using,Yes|No|NA,NA
biomarker,character,non-unique,optional,FALSE,"A measurable and quantifiable characteristic or substance that serves as an indicator of a biological state, condition, or process within an organism.",Adiponectin Measurement|Albumin Measurement|Alanine Aminotransferase Measurement|Aspartate Aminotransferase Measurement|Autoantibody titer measurement (procedure)|Direct Bilirubin Measurement|C-peptide Measurement|Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement|Cholesterol Measurement|Creatine Measurement|Creatinine Measurement|Diastolic Blood Pressure|Estimated Glomerular Filtration Rate|Erythrocyte Sedimentation Rate Measurement|fasting blood glucose measurement|fasting blood insulin measurement|Fibroblast Growth Factor 19 Measurement|Globulin Protein Measurement|Glucagon-like Peptide-1 Measurement|Glucose Measurement|Measurement of glutamate decarboxylase 65 antibody (procedure)|Glycosylated Hemoglobin Measurement|High Density Lipoprotein Cholesterol Measurement|Hemoglobinometry|High Sensitivity C-Reactive Protein Measurement|Interleukin 1 Measurement|International Normalized Ratio of Prothrombin Time|LDL Particles Measurement|Leptin Measurement|Prothrombin Time|Red blood cell count (procedure)|Systolic Blood Pressure|Triglyceride Measurement|Urea Nitrogen Measurement|White blood cell count (procedure),NCIT:C74839|NCIT:C64431|NCIT:C64433|NCIT:C64467|SNOMED:165848009|NCIT:C64481|NCIT:C74736|NCIT:C154728|NCIT:C105586|NCIT:C201455|NCIT:C64547|NCIT:C25299|NCIT:C110935|NCIT:C74611|EFO:0004465|EFO:0004466|NCIT:C154727|NCIT:C74738|NCIT:C80183|NCIT:C105585|SNOMED:117907009|NCIT:C64849|NCIT:C105587|OMIT:0007621|NCIT:C157114|NCIT:C74805|NCIT:C64805|NCIT:C120636|NCIT:C74866|NCIT:C62656|SNOMED:14089001|NCIT:C25298|NCIT:C64812|NCIT:C125949|SNOMED:767002
bmi,double,non-unique,optional,FALSE,body mass index (EFO:0004340): An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2).,[0-9]+\.?[0-9]*,NA
body_site,character,non-unique,required,FALSE,Subject's bodysite the given sample was collected from,elbow|skin epidermis|retroauricular region|vagina orifice|anterior naris|buccal mucosa|chest|hard palate|gingiva|left ear|lung|median vaginal canal|milk|nasal cavity|oral cavity|palatine tonsil|posterior fornix of vagina|rectum|right ear|saliva|sputum|feces|subgingival dental plaque|supragingival dental plaque|throat|dorsum of tongue|vagina|dentition|colon|sigmoid colon|lumbar vertebra 2|lumbar vertebra 3|lumbar vertebra 4|left colon|right colon,UBERON:0001461|UBERON:0001461|UBERON:0001003|UBERON:8480047|UBERON:8480047|UBERON:0012317|UBERON:2001427|UBERON:0006956|UBERON:0001443|UBERON:0003216|UBERON:0001828|UBERON:0035295|UBERON:0002048|UBERON:0013524|UBERON:0001913|UBERON:0001707|UBERON:0000167|UBERON:0002373|UBERON:0016486|UBERON:0001052|UBERON:0035174|UBERON:0001836|UBERON:0007311|UBERON:0001988|UBERON:0016484|UBERON:0016485|UBERON:0000341|UBERON:0009471|UBERON:0000996|UBERON:0003672|UBERON:0001052|UBERON:0001155|UBERON:0001159|UBERON:0004618|UBERON:0004619|UBERON:0004620|UBERON:0008971|UBERON:0008972|UBERON:0008971|UBERON:0008972
control,character,non-unique,required,FALSE,"Whether the sample is control, case, or not used in the study",Study Control|Case|Not Used,NCIT:C142703|NCIT:C49152|NCIT:C69062
country,character,non-unique,required,FALSE,Location where subject lives and/or data was collected,"Austria|Bangladesh|Brunei Darussalam|Cameroon|Canada|China|Denmark|El Salvador|Estonia|Ethiopia|Fiji|Finland|France|Germany|Ghana|Hungary|Iceland|India|Indonesia|Ireland|Israel|Italy|Japan|Kazakhstan|Liberia|Luxembourg|Madagascar|Malaysia|Mongolia|Netherlands|Norway|Peru|Philippines|Russian Federation|Singapore|Slovakia|Korea, Republic of|Spain|Sweden|Tanzania, United Republic of|United Kingdom|United States",NCIT:C16312|NCIT:C16323|NCIT:C16367|NCIT:C16379|NCIT:C16380|NCIT:C16428|NCIT:C16496|NCIT:C16532|NCIT:C16562|NCIT:C16563|NCIT:C16582|NCIT:C16584|NCIT:C16592|NCIT:C16636|NCIT:C26330|NCIT:C16699|NCIT:C16704|NCIT:C16727|NCIT:C16728|NCIT:C16757|NCIT:C16760|NCIT:C16761|NCIT:C16764|NCIT:C20107|NCIT:C16791|NCIT:C16803|NCIT:C16808|NCIT:C16814|NCIT:C16875|NCIT:C16903|NCIT:C16920|NCIT:C16972|NCIT:C16978|NCIT:C17111|NCIT:C17134|NCIT:C17669|NCIT:C16774|NCIT:C17152|NCIT:C17180|NCIT:C17185|NCIT:C17233|NCIT:C17234
curator,character,non-unique,required,TRUE,Curator name.,Paolo_Manghi|Valentina_Giunchiglia|Pamela_Ferretti|Marisa_Metzger|Giacomo_DAmato|Jacob_Wirbel|Arianna_Bonetti|Anna_Pedrotti|Francesca_DeFilippis|Aitor_Blanco_Miguez|Arianna_Bonetti;Anna_Pedrotti|Francesco_Asnicar;Paolo_Manghi|Ilya_Likhotkin;Paolo_Manghi|Aitor_Blanco_Miguez;Paolo_Manghi|Giacomo_Damato;Paolo_Manghi|Anna_Pedrotti;Paolo_Manghi|Mireia_VallesColomer|Andrew_Malthez_Thomas|Andrea_Zen|Bryan_Merrill,NA
days_from_first_collection,integer,non-unique,optional,FALSE,Used for time series studies.,[0-9]+,NA
dietary_restriction,character,non-unique,optional,FALSE,Dietary regime (partial match to SNOMED:182922004 or SNOMED:162536008),omnivore|vegan|vegetarian,NA
disease,character,non-unique,optional,TRUE,Reported disease/condition type(s) for a participant. 'Healthy' if disease(s)/condition(s) assessed under a given study is not detected,"Hernia of the abdominal wall|acute diarrhea|atherosclerosis|Alzheimer's Disease|adenocarcinoma|Adenoma|Allergic rhinitis|arthritis|ankylosing spondylitis|Ascaris lumbricoides|Ascites|Asthma|Behcet's syndrome|bronchitis|coronary artery disease|carcinoma|Crohn's disease|clostridium difficile infection|cellulitis|Cephalosporin Antibiotic|Cholera|Hypercholesterolemia|chorioamnionitis|cirrhosis of liver|cytomegalovirus infection|celiac disease|Study Control|Cough|Colorectal Carcinoma|cystitis|Donor|Entamoeba histolytica|Fatty Liver|Fever|Polyps|Schizophrenia|Fecal Microbiota Transplantation|gangrene|Diabetes Mellitus|gestational diabetes|hepatitis B virus infection|Hepatitis C Infection|hepatitis D virus infection|Healthy|Hepatitis|hepatitis E virus infection|Heart Failure|Hookworm Infection|human gut microbiome|human microbiome|human skin microbiome interaction|hypertension|Inflammatory Bowel Disease|abnormal glucose tolerance|indeterminate colitis|gastroenteritis|Intestinal Flora|Irritable Bowel Syndrome|large intestine adenoma|Metabolic Syndrome|Mansonella perstans|Multidrug-resistant bacteria (organism)|myalgic encephalomeyelitis/chronic fatigue syndrome|melanoma|Melanoma Surgery|metabolic syndrome|Metastatic Malignant Neoplasm|Metastatic Malignant Neoplasm in the Adrenal Gland|Metastatic Malignant Neoplasm in the Bone|Metastatic Malignant Neoplasm in the Liver|Metastatic Malignant Neoplasm in the Lung|Metastatic Malignant Neoplasm in the Lymph Nodes|Metastatic Squamous Cell Carcinoma|Loa loa|Microfilaria|Migraine|Mucositis|Non-alcoholic Fatty Liver Disease|Necator americanus|Natural Killer Cell|Oral Microbiome|Osteoarthritis|Otitis Media|Parkinson disease|Peri-Implantitis|Perianal fistula (disorder)|periodontitis|Plasmodium falciparum|pneumonia|preeclampsia|Pre-capillary pulmonary hypertension|premature birth|Prevotella copri|psoriasis|pyelonephritis|rheumatoid arthritis|Schizophrenia,repeated|Respiratory tract infection|salmonellosis|Schistosoma|Sepsis|Skin Infection|Small Intestinal Adenoma|Periodontal Scaling and Root Planing|Shiga Toxin-producing Escherichia coli|Helminth|stomatitis|Infection|Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus|Diarrhea|Tonsillitis|Colitis|Trichomonas|Trichuris trichiura|ulcerative colitis|undetermined colitis|Ureteric Stone|uveitis|Vogt-Koyanagi-Harada disease|Weight loss|Wilson disease|Wuchereria bancrofti",HP:0004299|MONDO:0000257|EFO:0003914|NCIT:C2866|EFO:0000228|NCIT:C2855|HP:0003193|EFO:0005856|EFO:0003898|NCIT:C122177|HP:0001541|NCIT:C28397|EFO:0003780|EFO:0009661|EFO:0001645|EFO:0000313|EFO:0000384|EFO:0009130|EFO:0003035|NCIT:C357|NCIT:C157812|HP:0003124|EFO:0009948|EFO:0001422|EFO:0001062|EFO:0001060|NCIT:C142703|HP:0012735|NCIT:C2955|EFO:1000025|NCIT:C48284|NCIT:C122297|OMIT:0006456|HP:0001945|OMIT:0012094|NCIT:C3362|NCIT:C118643|EFO:0008574|NCIT:C2985|EFO:0004593|EFO:0004197|NCIT:C3098|EFO:0007304|NCIT:C115935|HP:0012115|EFO:0007303|NCIT:C50577|NCIT:C34702|OHMI:0000020|OHMI:0000002|OHMI:0000121|EFO:0000537|NCIT:C3138|EFO:0002546|EFO:1000034|EFO:1001463|NCIT:C93019|NCIT:C82343|DOID:0050914|NCIT:C84442|NCIT:C119326|713351000|MONDO:0005404|EFO:0000756|NCIT:C157920|EFO:0000195|NCIT:C36263|NCIT:C8610|NCIT:C3580|NCIT:C4758|NCIT:C3577|NCIT:C4904|NCIT:C4104|NCIT:C123512|OMIT:0009896|NCIT:C89715|NCIT:C115965|OMIT:0028679|OMIT:0017611|NCIT:C12536|NCIT:C125208|NCIT:C3293|NCIT:C34885|MONDO:0005180|OMIT:0027030|58103005|EFO:0000649|NCBITaxon:5833|EFO:0003106|EFO:0000668|HP:0033578|EFO:0003917|NCBITaxon:165179|EFO:0000676|EFO:1001141|EFO:0000685|HP:0011947|MONDO:0000827|NCIT:C124285|HP:0100806|NCIT:C35025|NCIT:C5340|NCIT:C63714|NCIT:C184689|NCIT:C125642|EFO:0009688|NCIT:C128320|NCIT:C2986|NCIT:C26747|HP:0002014|NCIT:C116006|OMIT:0004401|NCIT:C89825|NCIT:C125973|EFO:0000729|MONDO:0015176|NCIT:C26902|EFO:1001231|MONDO:0018092|HP:0001824|MONDO:0010200|NCIT:C122328
disease_response_orr,character,non-unique,optional,FALSE,"Overal Response (ORR, NCIT:C96613): An assessment of the overall response of the disease to the therapy",Yes|No|NA,NA
disease_response_pfs,character,non-unique,optional,FALSE,"Progression Free Survival (PFS, EFO:0004920): Progression free survival is a measurement from a defined time point e.g. diagnosis and indicates that the disease did not progress i.e. tumours did not increase in size and new incidences did not occur. PFS is usually used in analyzing results of treatment for advanced disease.",Yes|No|NA,NA
disease_response_pfs_month,character,non-unique,optional,FALSE,A time point used to observe PFS. Unit is 'month',^[1-9]\d*(\.\d+)?$,NA
disease_response_recist,character,non-unique,optional,FALSE,"Response Evaluation Criteria in Solid Tumors (RECIST, DICOM:112022): Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (`respond`), stay the same (`stable`), or worsen (`progression`) during treatments. (from www.recist.com)",RECIST Complete Response|RECIST Partial Response|RECIST Progressive Disease|RECIST Stable Disease,NCIT:C159715|NCIT:C159547|NCIT:C159716|NCIT:C159546
dna_extraction_kit,character,non-unique,optional,FALSE,Name of the DNA extraction kit,Qiagen|Gnome|MoBio|MPBio|NorgenBiotek|Illuminakit|Maxwell_LEV|PSP_Spin_Stool|Tiangen|PowerSoil|Chemagen|other|PowerSoilPro|ZR_Fecal_DNA_MiniPrep|KAMA_Hyper_Prep|thermo_fisher|QIAamp,NA
family,character,non-unique,optional,FALSE,A number identifying the family subjects belong; not corrected for meta-analyses.,.+,NA
family_role,character,non-unique,optional,FALSE,Role in the family when multiple samples come from the same family but different persons.,child|mother|father,NA
feces_phenotype_metric,character,non-unique,optional,FALSE,"Measurements collected from stool sample, including observation, chemical test, and diagnostic procedure",Bristol stool form score (observable entity)|Calprotectin Measurement|Harvey-Bradshaw Index Clinical Classification,SNOMED:443172007|NCIT:C82005|NCIT:C191036
feces_phenotype_value,numeric,non-unique,optional,FALSE,Measured value for the metric specified under 'feces_phenotype_metric',^[1-9]\d*(\.\d+)?$,NA
fmt_id,character,non-unique,optional,TRUE,The id assigned to the FMT (Fecal microbiota transplantation) participants in the study,NA,NA
fmt_role,character,non-unique,optional,FALSE,"The role of the FMT (Fecal microbiota transplantation) participants. For recipient's samples, timing information (i.e., before or after FMT) is included as well.",Donor|Recipient (before procedure)|Recipient (after procedure),NA
hla,character,non-unique,optional,FALSE,HLA complex. A family of proteins that are essential for the presentation of peptide antigens on cell surfaces that modulate the host defensive activities of T-cells. This protein family includes major histocompatibility complex (MHC) class I and class II proteins.,HLA-DQB1*03:02 protein complex|HLA-DQB1*05:01 protein complex|HLA-DRB1*04:04 protein complex|HLA protein complex with DQ5 serotype|HLA protein complex with DQ2 serotype|HLA-DQB1*06:04 protein complex|HLA protein complex with DQ3 serotype|HLA-DRB1*04:01 protein complex|HLA protein complex with DQ4 serotype|HLA-DQB1*03:01 protein complex|HLA-DQA1*02:01 protein complex|HLA protein complex with DQ1 serotype|HLA-DRB1*04:02 protein complex|HLA-DRB1*04:05 protein complex|HLA-DRB1*04:08 protein complex,MRO:0001240|MRO:0001247|MRO:0001293|MRO:0001626|MRO:0001620|MRO:0001253|MRO:0001622|MRO:0001290|MRO:0001625|MRO:0001239|MRO:0001211|MRO:0001619|MRO:0001291|MRO:0001294|MRO:0001297
lifestyle,character,non-unique,optional,FALSE,to describe the lifestyle of non-westernized people,Hunter-gatherer|Agriculturalist|Agropastoralist|Pastoralist|Fisher,NA
location,character,non-unique,optional,FALSE,Free-form additional location information.,.+,NA
median_read_length,integer,non-unique,required,FALSE,Median read length - calculated from raw data.,[0-9]+|NA,NA
minimum_read_length,integer,non-unique,required,FALSE,Minimum read length - calculated from raw data.,[0-9]+|NA,NA
ncbi_accession,character,non-unique,optional,FALSE,A semicolon-separated vector of NCBI accessions,[ES]R[SR][0-9]+,NA
neonatal_birth_weight,numeric,non-unique,optional,FALSE,The mass or quantity of heaviness of an individual at BIRTH. (EFO:0004344),^[1-9]\d*(\.\d+)?$,NA
neonatal_delivery_procedure,character,non-unique,optional,FALSE,Description of the method by which a fetus is delivered. (NCIT:C81179),Elective Cesarean Delivery|Emergency Cesarean Delivery|Cesarean Section|Vaginal Delivery,NCIT:C114141|NCIT:C92772|NCIT:C46088|NCIT:C81303
neonatal_feeding_method,character,non-unique,optional,FALSE,"Infant feeding methods. 'Breastfeeding' refers feeding milk from human (include non-mother's and through bottle), 'mixed_feeding' refers both breastfeeding and formula feeding",exclusively_breastfeeding|exclusively_formula_feeding|mixed_feeding|no_breastfeeding,NA
neonatal_gestational_age,numeric,non-unique,optional,FALSE,"The age of the conceptus, beginning from the time of FERTILIZATION. (EFO:0005112)",^[1-9]\d*(\.\d+)?$,NA
neonatal_preterm_birth,character,non-unique,optional,FALSE,Birth when a fetus is less than 37 weeks and 0 days gestational age (NCIT:C92861).,Yes|No,NA
number_bases,double,non-unique,required,FALSE,Total number of bases sequenced in the sample - calculated from raw data.,[0-9]+,NA
number_reads,integer,non-unique,required,FALSE,Number of final reads - calculated from raw data.,[0-9]+,NA
obgyn_birth_control,character,non-unique,optional,FALSE,Use of birth control pill (Oral Contraceptive),Yes|No,NA
obgyn_lactating,character,non-unique,optional,FALSE,An indication that the subject is currently producing milk. (NCIT:C82463),Yes|No,NA
obgyn_menopause,character,non-unique,optional,FALSE,An indicator as to whether the female subject is in menopause,Premenopausal|Postmenopausal,NCIT:C15491|NCIT:C15421
obgyn_pregnancy,character,non-unique,optional,FALSE,The pregnancy status of an individual.,Pregnant|Not Pregnant,NCIT:C124295|NCIT:C82475
pmid,character,non-unique,optional,FALSE,Identifier of the main publication in PubMed,[0-9]{8},NA
population,character,non-unique,optional,FALSE,can describe the belonging to a specific population,[a-zA-Z]\S+,NA
probing_pocket_depth,numeric,non-unique,optional,FALSE,Depth of periodontal pocket (observable entity),[0-9]+,
sequencing_platform,character,non-unique,required,FALSE,This will be modified as new sequencing platforms are added to the database.,IlluminaHiSeq|IlluminaMiSeq|IlluminaNextSeq|IlluminaNovaSeq|IonProton,NA
sex,character,non-unique,optional,FALSE,Biological sex of the subject,Female|Male|NA,NCIT:C16576|NCIT:C20197
smoker,character,non-unique,optional,FALSE,Tobacco smoking behavior,smoker (finding)|Non-smoker (finding)|Ex-smoker (finding),SNOMED:77176002|SNOMED:8392000|SNOMED:8517006
subcohort,character,non-unique,optional,FALSE,Identifier of a sub-set of the cohort. Can be everything.,[0-9a-zA-Z]\S+,NA
target_condition,character,non-unique,required,TRUE,Main phenotype(s)/condition(s) of interest for a given study,human gut microbiome|Parkinson disease|Oral Microbiome|premature birth|Schizophrenia|rheumatoid arthritis|ankylosing spondylitis|Alzheimer's disease|gestational diabetes|chorioamnionitis|preeclampsia|acute diarrhea|Cholera|Prevotella copri|colorectal cancer|carcinoma|Adenoma|melanoma|Metastases status (attribute)|Peri-Implantitis|Mucositis|adenocarcinoma|Inflammatory Bowel Disease|Intestinal Flora|Type 1 Diabetes Mellitus|human microbiome|abnormal glucose tolerance|Type 2 Diabetes Mellitus|diarrhea|clostridium difficile infection|Multidrug-resistant bacteria (organism)|Crohn's disease|atherosclerosis|hypertension|metabolic syndrome|Shiga Toxin-producing Escherichia coli|Non-alcoholic Fatty Liver Disease|Weight loss|Metabolic Syndrome|control|Heart Failure|myalgic encephalomeyelitis/chronic fatigue syndrome|human skin microbiome interaction|cirrhosis of liver|Cephalosporin Antibiotic|Helminth|periodontitis|arthritis|psoriasis|otitis|pneumonia|bronchitis|Respiratory tract infection|sepsis|Skin Infection|Cough|gastroenteritis|Tonsillitis|pyelonephritis|cystitis|Fever|Infection|stomatitis|salmonellosis|Migraine|Asthma|Behcet's syndrome,OHMI:0000020|MONDO:0005180|NCIT:C125208|EFO:0003917|NCIT:C3362|EFO:0000685|EFO:0003898|EFO:0000249|EFO:0004593|EFO:0009948|EFO:0000668|DOID:0050140|NCIT:C157812|NCBITaxon:165179|EFO:0005842|EFO:0000313|NCIT:C2855|EFO:0000756|260874000|OMIT:0027030|NCIT:C115965|EFO:0000228|NCIT:C3138|NCIT:C93019|NCIT:C2986|OHMI:0000002|EFO:0002546|NCIT:C26747|MP:0005036|EFO:0009130|713351000|EFO:0000384|EFO:0003914|EFO:0000537|EFO:0000195|NCIT:C184689|OMIT:0028679|HP:0001824|NCIT:C84442|EFO:0001461|NCIT:C50577|MONDO:0005404|OHMI:0000121|EFO:0001422|NCIT:C357|NCIT:C125642|EFO:0000649|EFO:0005856|EFO:0000676|SYMP:0000873|EFO:0003106|EFO:0009661|HP:0011947|MP:0005044|NCIT:C35025|HP:0012735|EFO:1001463|NCIT:C116006|EFO:1001141|EFO:1000025|HP:0001945|NCIT:C128320|EFO:0009688|MONDO:0000827|NCIT:C89715|NCIT:C28397|EFO:0003780
treatment,character,non-unique,optional,TRUE,Medication(s)/treatment(s) applied to the subject,"EC 3.4.23.15 (renin) inhibitor|Olanzapine|red yeast rice supplement|Mesalamine|Acarbose|ACE Inhibitor|Albendazole|Amiodarone|Antihelminthic Agent|Antihypertensive Agent|Antiretroviral Therapy|Antiviral Agent|Anti-diabetic Agent|Antilipidemic Agent|Antineoplastic Agent|Thrombolytic Agent|Aspirin|Angiotensin II Receptor Antagonist|Azathioprine|Beta-Adrenergic Antagonist|Calcium Channel Blocker|Clopidogrel|Therapeutic Corticosteroid|Anti-CTLA-4 Monoclonal Antibody|Coumarin|Digitalis|Diuretic|Dopamine Antagonist|Dipeptidyl Peptidase-4 Inhibitor|Enteral Tube Feeding|Ezetimibe|Fibrate Antilipidemic Agent|Folate supplement (substance)|Dietary Supplement|Insulin Glargine|Thiazolidinedione Antidiabetic Agent|GLP-1 Mimetics|Heparin|Therapeutic Insulin|Ipilimumab|Iron|Insulin, NPH|Potassium-Sparing Diuretic|Lactulose|Laxative|Metformin|Metformin Hydrochloride|Methotrexate|Pediatric Nutritional Supplement Drink|Nitrate|Nivolumab|None|Insulin Aspart|Nonsteroidal Antiinflammatory Drug|Opioid|Antiarrhythmic Agent|Anti-PD1 Monoclonal Antibody|Pembrolizumab|Proton Pump Inhibitor|Probiotic|Reverse Transcriptase Inhibitor|SGLT2 Inhibitor|Sitagliptin|HMG-CoA Reductase Inhibitor|Steroid Compound|Sulfonylurea Antidiabetic Agent|Thiazide Diuretic|Citrate-containing Alkalinizing Agent|Xanthine Oxidase Inhibitor|Centrally acting hypotensive agent (substance)|Phenylpiperidine derivative (substance)",CHEBI:166822|NCIT:C47639|FOODON:03600010|NCIT:C29249|NCIT:C983|NCIT:C247|NCIT:C47384|NCIT:C62002|NCIT:C250|NCIT:C270|NCIT:C94631|NCIT:C281|NCIT:C29711|NCIT:C29703|NCIT:C274|NCIT:C29750|NCIT:C287|NCIT:C66930|NCIT:C290|NCIT:C29576|NCIT:C333|NCIT:C61686|NCIT:C211|NCIT:C128036|NCIT:C397|NCIT:C65385|NCIT:C448|NCIT:C66883|NCIT:C98086|NCIT:C93322|NCIT:C47529|NCIT:C98150|SNOMED:438451000124100|NCIT:C1505|NCIT:C47564|NCIT:C98241|NCIT:C98085|NCIT:C539|NCIT:C581|NCIT:C2654|NCIT:C598|NCIT:C29124|NCIT:C49186|NCIT:C29148|NCIT:C29697|NCIT:C61612|NCIT:C29251|NCIT:C642|NCIT:C74453|NCIT:C80487|NCIT:C68814|NCIT:C41132|NCIT:C47563|NCIT:C257|NCIT:C1506|NCIT:C47793|NCIT:C128037|NCIT:C106432|NCIT:C29723|NCIT:C93144|NCIT:C1589|NCIT:C98083|NCIT:C73838|NCIT:C1655|NCIT:C843|NCIT:C97936|NCIT:C49185|NCIT:C29369|NCIT:C1637|SNOMED:372740001|SNOMED:48070003
tumor_staging_ajcc,character,non-unique,optional,FALSE,A system to describe the amount and spread of cancer in a patient's body,0|I|II|III|IV|III/IV,NA
tumor_staging_tnm,character,non-unique,optional,FALSE,A system to describe the amount and spread of cancer in a patient's body,t[1-4]n[0-3]m[0-1],NA
uncurated_metadata,character,non-unique,optional,FALSE,Additional information that doesn't belong to the existing fields,.+,NA
westernized,character,non-unique,optional,FALSE,"Subject adopt or be influenced by the cultural, economic, or political systems of Europe and North America.",Yes|No,NA
zigosity,character,non-unique,optional,FALSE,Zigosity.,monozygotic|dizygotic,NA
